BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook

Reuters

02/27

** Healthcare company Grifols GRLS.MC sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026

** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026

** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling

** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth

** The company's shares are on track for its worst day since April 2025

(Reporting by Gemma Guasch)

((Gemma.guasch@thomsonreuters.com ;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2614835937"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614835937\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614835937?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614835937","market":"fut","top_or_hot":-1,"title":"BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook</title></head><body><p>** Healthcare company Grifols <span>GRLS.MC</span> sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026</p><p>** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026</p><p>** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling</p><p>** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth</p><p>** The company's shares are on track for its worst day since April 2025</p><p> (Reporting by Gemma Guasch)</p><p> ((Gemma.guasch@thomsonreuters.com ;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-27 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook</title></head><body><p>** Healthcare company Grifols <span>GRLS.MC</span> sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026</p><p>** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026</p><p>** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling</p><p>** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth</p><p>** The company's shares are on track for its worst day since April 2025</p><p> (Reporting by Gemma Guasch)</p><p> ((Gemma.guasch@thomsonreuters.com ;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健护理机构","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN0VJ:1","article_id":"2614835937","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614835937","pubTimestamp":1772184285,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook** Healthcare company Grifols GRLS.MC sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth** The company's shares are on track for its worst day since April 2025  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","ACHC":"阿卡迪亚医疗保健公司"},"translate_title":"BUZZ-Grifols因2026年收入增长前景疲弱而跌至IBEX底部","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACHC":0.9},"content_text":"BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook** Healthcare company Grifols GRLS.MC sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth** The company's shares are on track for its worst day since April 2025 (Reporting by Gemma Guasch) ((Gemma.guasch@thomsonreuters.com ;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}